Q-1806

N/A

Report date: 2024/12/12 16:37:27

Base Information

Drug NameQ-1806
Drug Alias NameQ-1806
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibody
Mechanisms of ActionProgrammed death-ligand 1 modulatorsVascular endothelial growth factor modulatorsTGF-β pathway modulators
TargetsProgrammed death-ligand 1Vascular endothelial growth factorTransforming growth factor beta
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesQure Biotechnology (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQure Biotechnology (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A